Cytek Biosciences (CTKB) Introduces Cytek Cloud
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Four banks form $63B financing vehicle for Broadcom AI chips leased to Anthropic
Cytek® Biosciences Introduces Cytek Cloud
November 15, 2022 10:00 AM ESTNew Digital Ecosystem Supports Full Spectrum Flow Cytometry Research from Panel Design to Data Acquisition
FREMONT, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the launch of Cytek Cloud a cloud-based platform that features two integrated tools to streamline workflows on Cyteks state-of-the-art cell sorters and analyzers. Optimized for Cytek systems and reagents, Cytek Cloud joins the companys extensive suite... More



